search
Back to results

DIATEST - mHealth and Type 2 Diabetes Mellitus (DIATEST)

Primary Purpose

Diabetes Mellitus, Type 2

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
FoodSwitch
Sponsored by
Linkoeping University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Diabetes Mellitus, Type 2

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: age 18-75 years regularly participate in grocery shopping self-report of having T2DM, with or without diabetes medication Exclusion Criteria: no access to BankID (a digital identification system commonly used in Sweden), thus unable to consent to the study fail to complete the run-in procedures HbA1c <48 mmol/mol in combination with no ongoing diabetes treatment

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    Intervention

    Control

    Arm Description

    Access to the 'DiabetesSwitch' filter of the FoodSwitch app when food shopping during 26 weeks.

    Access to written dietary advice during 26 weeks.

    Outcomes

    Primary Outcome Measures

    HbA1c (mmol/mol)
    Hemoglobin A1C (mmol/mol)

    Secondary Outcome Measures

    Total cholesterol (mmol/l)
    Total cholesterol (mmol/l)
    LDL (mmol/l)
    Low-density lipoprotein (mmol/l)
    HDL (mmol/l)
    High-density lipoprotein (mmol/l)
    eGFR (ml/min)
    Estimated glomerular filtration rate (ml/min)
    TNF-α (ng/L)
    Tumor necrosis factor - alpha (ng/L)
    IL-1β (ng/L)
    Interleukin 1β (ng/L)
    IL-6 (ng/L)
    Interleukin 6 (ng/L)
    hsCRP (mg/L)
    High sensitive c-reactive protein (mg/L)
    Proteomics, and metabolomics
    The analysis of proteomics and metabolomics is explorative, and therefore the selection of proteins and metabolites is not pre-determined but will rather include those that are available and deemed appropriate at the time of analysis
    Albuminuria (mg/l)
    Albuminuria (mg/l)
    Self-measured waist circumference (cm)
    Self-measured waist circumference (cm)
    Self-reported quality of life
    Self-reported quality of life - questionnaire

    Full Information

    First Posted
    July 6, 2023
    Last Updated
    July 28, 2023
    Sponsor
    Linkoeping University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05977218
    Brief Title
    DIATEST - mHealth and Type 2 Diabetes Mellitus
    Acronym
    DIATEST
    Official Title
    DIATEST - a mHealth Intervention to Improve Clinical Management of Type 2 Diabetes Mellitus
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    January 1, 2024 (Anticipated)
    Primary Completion Date
    December 31, 2029 (Anticipated)
    Study Completion Date
    December 31, 2029 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Linkoeping University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Dietary modification is effective in the prevention and treatment of type 2 diabetes mellitus (T2DM). However, the access to dieticians in primary care is limited. While mHealth tools have been shown to improve diet and clinical management of patients with T2DM, there are currently no mobile health (mHealth) tools that are effective in improving diet and clinical management of T2DM in Sweden. The aim of this project is to study the effect of the FoodSwitch app, an mHealth intervention for patients with T2DM.
    Detailed Description
    This randomized controlled trial will determine the effect of the FoodSwitch app for healthier food choices on HbA1c, blood lipids, renal function and low-grade inflammation in individuals with T2DM. The effect of the mHealth tool on HbA1c and cardiovascular risk factors, will be compared to standard dietary advice for patients with T2DM. Randomization will be performed in a 1:1 ratio to receive the FoodSwitch app intervention or control and stratified by age (<50 years/≥50 years), sex, and baseline insulin use (Yes/No). The intervention group will scan all their purchased packaged food with the FoodSwitch app for one week at 6 and 12, 18 and 26 weeks. The control group will photograph and upload images of their receipts or share digital shopping receipts for one week at 6 and 12, 18 and 26 weeks. All participants in both the intervention and control group will report symptoms, functions, and quality of life, as often as they like as well as at 6 and 12, 18 and 26 weeks. All participants will be mailed a blood and urine collection kit and instructed to use it and to self-measure waist circumference at the start of the study and at 26 weeks. The primary outcome (HbA1c) and secondary outcomes (blood measurements of total cholesterol, LDL and HDL cholesterol, eGFR, TNF-α, IL-1β, IL-6, CRP, proteomics, and metabolomics; microalbuminuria; self-measured waist circumference; self-reported quality of life, 24-hour dietary recall, as well as other present symptoms; smartphone-obtained physical activity levels and patterns) will be evaluated at 26 weeks. National registry-obtained data on medication use, hospitalizations and deaths will also be evaluated.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Diabetes Mellitus, Type 2

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    900 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Intervention
    Arm Type
    Experimental
    Arm Description
    Access to the 'DiabetesSwitch' filter of the FoodSwitch app when food shopping during 26 weeks.
    Arm Title
    Control
    Arm Type
    No Intervention
    Arm Description
    Access to written dietary advice during 26 weeks.
    Intervention Type
    Other
    Intervention Name(s)
    FoodSwitch
    Intervention Description
    Access to the 'DiabetesSwitch' filter of the FoodSwitch app when food shopping. When a packaged food item bar code is scanned, the FoodSwitch app will show an interpretive nutritional information score for the scanned product and recommend alternate healthier food options in the same category.
    Primary Outcome Measure Information:
    Title
    HbA1c (mmol/mol)
    Description
    Hemoglobin A1C (mmol/mol)
    Time Frame
    Change from baseline at week 26
    Secondary Outcome Measure Information:
    Title
    Total cholesterol (mmol/l)
    Description
    Total cholesterol (mmol/l)
    Time Frame
    Change from baseline at week 26
    Title
    LDL (mmol/l)
    Description
    Low-density lipoprotein (mmol/l)
    Time Frame
    Change from baseline at week 26
    Title
    HDL (mmol/l)
    Description
    High-density lipoprotein (mmol/l)
    Time Frame
    Change from baseline at week 26
    Title
    eGFR (ml/min)
    Description
    Estimated glomerular filtration rate (ml/min)
    Time Frame
    Change from baseline at week 26
    Title
    TNF-α (ng/L)
    Description
    Tumor necrosis factor - alpha (ng/L)
    Time Frame
    Change from baseline at week 26
    Title
    IL-1β (ng/L)
    Description
    Interleukin 1β (ng/L)
    Time Frame
    Change from baseline at week 26
    Title
    IL-6 (ng/L)
    Description
    Interleukin 6 (ng/L)
    Time Frame
    Change from baseline at week 26
    Title
    hsCRP (mg/L)
    Description
    High sensitive c-reactive protein (mg/L)
    Time Frame
    Change from baseline at week 26
    Title
    Proteomics, and metabolomics
    Description
    The analysis of proteomics and metabolomics is explorative, and therefore the selection of proteins and metabolites is not pre-determined but will rather include those that are available and deemed appropriate at the time of analysis
    Time Frame
    Change from baseline at week 26
    Title
    Albuminuria (mg/l)
    Description
    Albuminuria (mg/l)
    Time Frame
    Change from baseline at week 26
    Title
    Self-measured waist circumference (cm)
    Description
    Self-measured waist circumference (cm)
    Time Frame
    Change from baseline at week 26
    Title
    Self-reported quality of life
    Description
    Self-reported quality of life - questionnaire
    Time Frame
    Change from baseline at week 26
    Other Pre-specified Outcome Measures:
    Title
    24-hour dietary recall
    Description
    24-hour dietary recall
    Time Frame
    Change from baseline at week 26

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: age 18-75 years regularly participate in grocery shopping self-report of having T2DM, with or without diabetes medication Exclusion Criteria: no access to BankID (a digital identification system commonly used in Sweden), thus unable to consent to the study fail to complete the run-in procedures HbA1c <48 mmol/mol in combination with no ongoing diabetes treatment
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Lana Hebib, MD
    Phone
    013-28 10 00
    Email
    lana.hebib@liu.se
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Karin Rådholm, MD, PhD
    Organizational Affiliation
    Linkoeping University
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Time Frame
    After publication in a peer-reviewed journal and for the period of time for which local archive regulations stipulate.
    IPD Sharing Access Criteria
    To be determined on a case by case basis.
    Citations:
    PubMed Identifier
    25147135
    Citation
    Dunford E, Trevena H, Goodsell C, Ng KH, Webster J, Millis A, Goldstein S, Hugueniot O, Neal B. FoodSwitch: A Mobile Phone App to Enable Consumers to Make Healthier Food Choices and Crowdsourcing of National Food Composition Data. JMIR Mhealth Uhealth. 2014 Aug 21;2(3):e37. doi: 10.2196/mhealth.3230.
    Results Reference
    background
    PubMed Identifier
    26819969
    Citation
    Coughlin SS, Whitehead M, Sheats JQ, Mastromonico J, Hardy D, Smith SA. Smartphone Applications for Promoting Healthy Diet and Nutrition: A Literature Review. Jacobs J Food Nutr. 2015;2(3):021.
    Results Reference
    background

    Learn more about this trial

    DIATEST - mHealth and Type 2 Diabetes Mellitus

    We'll reach out to this number within 24 hrs